AKT-eNOS-NO pathway mediates spontaneous portosystemic shunts and therapeutic efficacy of SC79 in cirrhosis

doi:10.3748/wjg.119990

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 36

This Article

(6)

(0)

(17)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Sep 28, 2026; 32(36): 119990
Published online Sep 28, 2026. doi: 10.3748/wjg.119990

Full Size Figure Download Figure

Figure 3 Metabolomic profiling identifies dysregulated pathways associated with spontaneous portosystemic shunts. A and B: Permutation tests in positive and negative ion modes; C and D: Orthogonal Partial Least Squares Discriminant Analysis score plots in positive and negative ion modes; E: Number of differential metabolites between spontaneous portosystemic shunts (SPSS) and non-SPSS groups; F: Volcano plot of differential metabolites; G: Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis. OPLS-DA: Orthogonal Partial Least Squares Discriminant Analysis; FC: Fold change; SPSS: Spontaneous portosystemic shunts.

Citation: Ke Q, Guo ZT, He J, Huang XH, Lei XJ, Zhuang QY, Zhou Y, Li L, Wang YC, Liu JF, Guo WH. AKT-eNOS-NO pathway mediates spontaneous portosystemic shunts and therapeutic efficacy of SC79 in cirrhosis. World J Gastroenterol 2026; 32(36): 119990
URL: https://www.wjgnet.com/1007-9327/full/v32/i36/119990.htm
DOI: https://dx.doi.org/10.3748/wjg.119990

Ke Q, Guo ZT, He J, Huang XH, Lei XJ, Zhuang QY, Zhou Y, Li L, Wang YC, Liu JF, Guo WH. AKT-eNOS-NO pathway mediates spontaneous portosystemic shunts and therapeutic efficacy of SC79 in cirrhosis. World J Gastroenterol 2026; 32(36): 119990 [DOI: 10.3748/wjg.119990]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.